CURRENT AFFAIRS

Detailed explanation-1: -Today, the U.S. Food and Drug Administration issued an emergency use authorization for the investigational antiviral drug remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.

Detailed explanation-2: -Approved Drugs Olumiant (baricitinib) is approved for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

Detailed explanation-3: -Remdesivir is a nucleotide analogue prodrug that is approved to treat COVID-19 in certain patients.

Detailed explanation-4: -Antiviral Agents, Including Antibody Products. Remdesivir is the only antiviral drug that is approved by the Food and Drug Administration (FDA) for the treatment of COVID-19.

Detailed explanation-5: -Remdesivir is to be used only in select moderate/ severe hospitalised Covid - 19 patients on supplemental oxygen as it is a reserve drug approved under Emergency Use Authorization only based on limited scientific evidence globally.